Table 3.
Outcome related to working situation among patients who worked before COVID-19.
| Working before COVID-19, n = 32 |
Working before COVID-19, n = 32 |
|||||
|---|---|---|---|---|---|---|
| 3–6 month | 3–6 month | 12 month | 12 month | |||
| Returned to work, n = 20 | Not returned to work, n = 12 | p-value | Returned to work, n = 22 | Not returned to work, n = 10 | p-value | |
| Age | 56 (53–61) | 58 (50–67) | 0.640 | 56 (52–61) | 59 (53–65) | 0.370 |
| Sex (female) | 5 (25) | 1 (8) | 0.250 | 5 (23) | 1 (10) | 0.400 |
| SAPS3 | 50 (46–53) | 53 (46–57) | 0.159 | 51 (46–56) | 51 (46–53) | 0.759 |
| Invasiv ventilation therapy (Days with invasive ventilation therapy) |
5 (25) 0 (0–1.5) |
11 (92) 10.5 (6–22) |
0.000 0.000 |
10 (46) 0 (0–8.5) |
6 (60) 7 (0–28) |
0.453 0.215 |
| Days in ICU |
7 (4–12) | 21 (9–37) | 0.005 | 8 (6–14) | 15 (3–40) | 0.541 |
| Education (≥12 years) | 12 (60) | 5 (42) | 0.322 | 12 (55) | 5 (50) | 0.814 |
| Outcome | ||||||
| EQ-5D-5L | ||||||
| Mobility | 1 (1–2) | 2 (1–2) | 0.209 | 1 (1–1) | 2 (2–3) | 0.001 |
| Self-Care | 1 (1–1) | 1 (1–2) | 0.477 | 1 (1–1) | 1 (1–2) | 0.182 |
| Usual Activity | 1 (1–2) | 3 (2–5) | 0.003 | 1 (1–2) | 3 (2–5) | 0.004 |
| Pain/discomfort | 2 (1–3) | 3 (2–3) | 0.307 | 2 (1–3) | 3 (2–3) | 0.659 |
| Anxiety/Depression | 1 (1–2) | 1 (1–3) | 0.058 | 1 (1–2) | 2 (2–3) | 0.136 |
| EQ-VAS | 75 (66–90) | 68 (51–80) | 0.170 | 80 (69–93) | 53 (48–76) | 0.003 |
| MoCA | 28 (26–29) | 25 (22–28) | 0.019 | 29 (27–29) | 28 (26–28) | 0.046 |
| MFI General fatigue | 10 (6–12) | 17 (8–19) | 0.104 | 12 (8–15) | 16 (15–18) | 0.014 |
| MFI Physical fatigue | 12 (8–17) | 15 (10–18) | 0.407 | 11 (8–15) | 16 (11–19) | 0.013 |
| MFI Mental fatigue | 12 (6–15) | 17 (8–20) | 0.082 | 8 (6–10) | 11 (6–18) | 0.121 |
| MFI reduced motivation | 10 (6–12) | 12 (8–16) | 0.279 | 8 (6–11) | 8 (6–11) | 1.000 |
| MFI reduced activity | 8 (6–11) | 9 (4–11) | 0.967 | 9 (6–14) | 14 (10–17) | 0.022 |
| PHQ9 | 3 (1–8) | 7 (1–11) | 0.338 | 2 (0–5) | 9 (4–15) | 0.012 |
| GAD7 | 3 (0–4) | 4 (0–7) | 0.270 | 1 (0–2) | 5 (3–10) | 0.002 |
| 6MWT | 560 (522–629) | 410 (363–539) | 0.004 | 558 (505–613) | 461 (390–578) | 0.132 |
Categorical data presented as number of total, n (percentage) and compared using Wilcoxon signed-rank test. Continuous data presented as median with interquartile range (IQR) and compared with Mann-Whitney U test. 6MWT: 6-minute walk test, CFS: Clinical Frailty Scale, GAD-7: Generalised Anxiety Disorder 7-item scale, ICU: intensive care unit, MoCA: Montreal Cognitive Assessment, MFI 20: Multidimensional Fatigue Inventory, mRS: modified Rankin Scale, PCFS: Post-COVID-19 Functional Status Scale, PHQ-9: Patient Depression Questionnaire.